Menu
Close
News

UW set to resume enrollment for AstraZeneca’s investigational COVID-19 vaccine

October 28, 2020
Science & Technology
Share

A clinical trial of an investigational COVID-19 vaccine has resumed in the United States after the FDA and an independent safety review board completed their review of a trial participant in the United Kingdom who became ill.

UW received approval on Friday, Oct. 23 to reopen its clinical trial of AstraZeneca’s investigational COVID-19 vaccine. The trial should officially resume next week. Thirty-six participants received the first of two shots before the study was paused on Sept. 6, and they continued to receive study-related checkups and blood draws throughout the pause period. Those participants will now have the option to receive their second dose. No additional participants were enrolled during the pause.

Enrollment is expected to resume over the next several weeks, and the UW study team will begin contacting individuals who had previously expressed interest in participating in the trial. Participants at all study locations will need to complete a revised informed consent form that includes updated safety information.

UW Health and the UW School of Medicine and Public Health want the public to know that the safety of all clinical trials, including vaccine trials, is paramount.

“We are thrilled to be back. These extensive reviews show that experts have the best interest of the public at heart,” said William Hartman, MD, PhD, principal investigator for the trial and an assistant professor of anesthesiology. “A single patient out of 20,000 worldwide developed an unexplained illness and the trial was halted. They took the time to figure out the safety. The system works.”

Participate in the trial

Individuals interested in learning more about participating in the study are encouraged to email uwcovidvaccine@clinicaltrials.wisc.edu or call the hotline at 608-262-8300 or 833-306-0681.

Editor’s note: Recruitment is complete and the study team is no longer seeking volunteers.

Tags
COVID-19

More News

Health & Wellness
November 10, 2020

Requiring basic level of health care coverage is important for healthy people and communities

On Nov. 10, the United States Supreme Court is considering oral arguments in two cases related to the requirement that all Americans maintain health insurance coverage. The health impact of this straightforward governmental mandate is broad-reaching and should be maintained in the interest of protecting the health of Americans, advises Robert N. Golden, MD, Dean, University of Wisconsin School of Medicine and Public Health and Vice Chancellor for Medical Affairs.
Two students walk down the sidewalk together while social distancing
Science & Technology
October 27, 2020

COVID-19 data model quantifies region-specific impact of social distancing orders

As the COVID-19 pandemic first took hold in regions across the United States in spring 2020, local officials, hoping to quell the spread of the virus, turned to the only actionable defenses available at the time: closing schools and businesses, banning mass gatherings, issuing stay-at-home orders and enforcing other social distancing measures.